These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 13847126)

  • 1. Experimental pathology of iproniazid and related compounds.
    ZBINDEN G; STUDER A
    Ann N Y Acad Sci; 1959 Sep; 80():873-84. PubMed ID: 13847126
    [No Abstract]   [Full Text] [Related]  

  • 2. [On quantitative differences in the effect between 1-isonicotinoyl-2-isopropyl hydrazine (iproniazid) and isopropyl hydrazine on monoamine oxidase].
    HEIM F; DIEMER K
    Med Exp Int J Exp Med; 1960; 3():249-51. PubMed ID: 13712856
    [No Abstract]   [Full Text] [Related]  

  • 3. [The influence of iproniazid and beta-phenylisopropylhydrazine (JB516) on the narcotic effect and decomposition of hexobarbital and thiopental].
    ARRIGONI-MARTELLI E; KRAMER M
    Med Exp Int J Exp Med; 1959; 1():45-51. PubMed ID: 13794503
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835).
    SPECTOR S; SHORE PA; BRODIE BB
    J Pharmacol Exp Ther; 1960 Jan; 128():15-21. PubMed ID: 13833205
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of the in vivo inhibition of brain and liver monoamine oxidase as produced by beta-phenylisopropylhydrazine (PIH) and iproniazid.
    GOGERTY JH; HORITA A
    J Pharmacol Exp Ther; 1960 Aug; 129():357-60. PubMed ID: 13850477
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of diamine oxidase in vivo by hydrazine derivatives.
    BURKARD WP; GEY KF; PLETSCHER A
    Biochem Pharmacol; 1960 Jul; 3():249-55. PubMed ID: 13806127
    [No Abstract]   [Full Text] [Related]  

  • 7. Intracellular distribution of norepinephrine in rat brain. I. Effect of reserpine and the monoamine oxidase inhibitors, trans-2-phenylcyclopropylamine and 1-isonicotinyl-2-isopropyl hydrazine.
    GREEN H; SAWYER JL
    J Pharmacol Exp Ther; 1960 Jul; 129():243-9. PubMed ID: 13851489
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of iproniazid and similar compounds on the gastrointestinal tract.
    WEISS J; WEISS S; WEISS B
    Ann N Y Acad Sci; 1959 Sep; 80():854-9. PubMed ID: 13843720
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the adrenergic action of iproniazid, inhibitor of monoamine oxidase].
    MEYER F
    C R Hebd Seances Acad Sci; 1961 Apr; 252():2616-8. PubMed ID: 13769974
    [No Abstract]   [Full Text] [Related]  

  • 10. Facilitation of metrazol-in-duced seizures by iproniazid and betaphenylisopropylhy-drazine in mice.
    SPOERLEIN MT; ELLMAN AM
    Arch Int Pharmacodyn Ther; 1961; 133():193-9. PubMed ID: 13915887
    [No Abstract]   [Full Text] [Related]  

  • 11. Central effects of beta-phenylisopropylhydrazine and iproniazid.
    FURGIUELE AR; KINNARD WJ; BUCKLEY JP
    J Pharmacol Exp Ther; 1962 Sep; 137():356-60. PubMed ID: 13895937
    [No Abstract]   [Full Text] [Related]  

  • 12. [Action of nialamide on coronary circulation. The influence exerted by a serotonin antagonist on the action of nialamide and of iproniazid].
    GAVEND M; GAVEND MR; MERCIER J
    C R Seances Soc Biol Fil; 1960; 154():2089-92. PubMed ID: 24545639
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of trans-2-phenylcycloproplylamine upon norepinephrine concentration and monamine oxidase activity of rat brain.
    GREEN H; ERICKSON RW
    J Pharmacol Exp Ther; 1960 Jul; 129():237-42. PubMed ID: 13851486
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective depression of sympathetic transmission by intravenous administration of iproniazid and harmine.
    GOLDBERG LI; DACOSTA FM
    Proc Soc Exp Biol Med; 1960 Nov; 105():223-7. PubMed ID: 13706462
    [No Abstract]   [Full Text] [Related]  

  • 15. Physiological significance of monoamine oxidase.
    IMAIZUMI R; OMORI K; UNOKI A; SANO K; WATARI Y; NAMBA J; INUI K
    Jpn J Pharmacol; 1959 Mar; 8():87-95. PubMed ID: 13852733
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative trial of four monoamine oxidase inhibitors on chronic depressives.
    BATES TJ; DOUGLAS AD
    J Ment Sci; 1961 May; 107():538-46. PubMed ID: 13687739
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurophysiological studies with monoamine oxidase inhibitors.
    SCHALLEK W
    Dis Nerv Syst; 1960 Mar; 21(3)Suppl():64-6. PubMed ID: 14442400
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of iproniazid with other amine oxidase inhibitors, including W-1544, JB-516, RO 4-1018, and RO 5-0700.
    BAILEY SD; BUCCI L; GOSLINE E; KLINE NS; PARK IH; ROCHLIN D; SAUNDERS JC; VAISBERG M
    Ann N Y Acad Sci; 1959 Sep; 80():652-68. PubMed ID: 13795859
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the active center of monoamine oxidase.
    ZELLER EA
    Experientia; 1960 Sep; 16():399-402. PubMed ID: 13788171
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of monoamine oxidase inhibitors and tryptophan on the tryptamine content of animal tissues and urine.
    HESS SM; REDFIELD BG; UDENFRIEND S
    J Pharmacol Exp Ther; 1959 Nov; 127():178-81. PubMed ID: 14401504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.